Skip to main content
    M

    Merit Medical Systems Inc (MMSI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $84.49
    -1.86 (-2.15%)

    Market Cap: $5.17B

    Last updated: Nov 17, 2026 at 4:26 PM ET

    Merit Medical Systems Inc (MMSI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Merit Medical Systems (MMSI) has a market cap of $5.17B and an enterprise value of $5.41B. Its trailing P/E of 20.7x is below its 10-year median of 27.6x.

    Total Valuation

    Enterprise value is 4.52% above the market cap, as debt exceeds cash.

    Market Cap$5.17B
    Enterprise Value$5.41B
    Latest price (Nov 17, 2026)$84.49

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.21% in the quarter ended Sep 30, 2026 and grew 1.34% a year over 2 years.

    Shares Outstanding59.81M
    Shares Change (YoY)+0.95%
    Shares Change (QoQ)+0.21%
    Share Count Growth (2Y CAGR)+1.34%

    Valuation Ratios

    Sales and book value multiples are 3.1x and 2.9x. Its year-end P/E ranged from 21.2x to 33.6x from 2016 to 2025.

    P/E Ratio20.7x
    Forward P/E19.0x
    P/S Ratio3.1x
    Forward P/S3.2x
    P/B Ratio2.9x
    P/TBV Ratio8.2x
    P/FCF Ratio24.8x
    P/OCF Ratio18.9x
    PEG Ratio2.6

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 14.3x EBITDA and 26.0x free cash flow.

    EV / Earnings33.8x
    EV / Sales3.4x
    EV / EBITDA14.3x
    EV / EBIT23.7x
    EV / FCF26.0x

    Price Statistics

    The stock is down 0.71% over 52 weeks and trades 3.88% below its 50-day average.

    Beta (1Y)0.51
    52-Week Change-0.71%
    1-Month Change-6.08%
    3-Month Change-8.14%
    6-Month Change+32.49%
    5-Year Change+28.22%
    10-Year Change+292.89%
    Total Return (1Y)-0.71%
    Total Return (3Y CAGR)+5.79%
    Total Return (5Y CAGR)+4.41%
    Return vs SPY (1Y)-11.18%
    Max Drawdown (1Y)-35.28%
    Max Drawdown (3Y)-45.32%
    Sharpe Ratio (1Y)0.01
    Correlation with SPY (1Y)0.23
    50-Day Average$87.90
    200-Day Average$77.26
    52-Week Range$59.74 to $94.85
    RSI (14 Days)40.2
    Average Volume (20 Days)756.78K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.52x current liabilities, and total debt is 0.42x shareholder equity.

    Current Ratio4.52x
    Quick Ratio3.05x
    Debt / Equity0.42x
    Debt / EBITDA1.99x
    Debt / FCF3.62x
    Interest Coverage7.06x

    Returns and Efficiency

    Return on invested capital is 6.96% over the last 12 months, against a 5-year average of 5.32%.

    Return on Equity (ROE)9.18%
    Return on Assets (ROA)5.47%
    Return on Invested Capital (ROIC)6.96%
    Return on Capital Employed (ROCE)8.59%
    ROE (5Y Average)7.17%
    ROA (5Y Average)4.25%
    ROIC (5Y Average)5.32%
    Asset Turnover0.58x
    Inventory Turnover2.13x
    Receivables Turnover7.22x
    Cash Conversion Cycle191 days

    Taxes

    Income tax took 24.37% of pretax income over the last 12 months.

    Income Tax (TTM)$51.59M
    Effective Tax Rate24.37%

    Scores

    MMSI has an Altman Z-Score of 4.21, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score4.21
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.61B over the last 12 months is up 9.06% from the 12 months before.

    Revenue$1.61B
    Revenue Growth (YoY)+9.06%
    Gross Profit$795.95M
    Operating Income$217.52M
    Pretax Income$211.71M
    Net Income$160.12M
    EBITDA$370.40M
    EBIT$228.36M
    Reported EPS (TTM)$4.08

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 59.59% of the $2.92B in total assets.

    Cash and Equivalents$503.55M
    Total Debt$737.40M
    Net Debt$233.85M
    Net Debt Per Share$3.91
    Working Capital$933.73M
    Shareholder Equity$1.74B
    Book Value Per Share$29.17
    Tangible Book Value$616.21M
    Tangible Book Per Share$10.30
    Total Assets$2.92B
    Total Liabilities$1.18B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $70.15M of capital spending, operating cash flow left $203.59M of free cash flow.

    Operating Cash Flow$273.74M
    Capital Expenditures$70.15M
    Free Cash Flow$203.59M
    FCF Per Share$3.41
    Depreciation and Amortization$142.03M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 13.50%, against a 5-year average of 9.36%.

    Gross Margin49.41%
    Operating Margin13.50%
    Pretax Margin13.14%
    Net Margin9.94%
    EBITDA Margin22.99%
    EBIT Margin14.18%
    FCF Margin12.64%
    Gross Margin (5Y Average)46.56%
    Operating Margin (5Y Average)9.36%
    Net Margin (5Y Average)7.17%

    Growth

    Revenue grew 9.61% a year over 3 years, and EPS 12.50% a year.

    Revenue Growth (3Y CAGR)+9.61%
    Revenue Growth (5Y CAGR)+9.48%
    EPS Growth (3Y CAGR)+12.50%
    EPS Growth (5Y CAGR)+18.34%
    FCF Growth (3Y CAGR)+46.02%
    FCF Growth (5Y CAGR)+12.57%
    Operating Income Growth (3Y CAGR)+28.25%
    Book Value Per Share Growth (2Y CAGR)+13.23%
    Tangible Book Per Share Growth (2Y CAGR)+3.11%

    Revenue and profit by year

    Dividends and Yields

    MMSI does not pay a dividend. Its free cash flow yield is 4.03%.

    Earnings Yield4.83%
    FCF Yield4.03%
    Buyback Yield-0.44%
    Shareholder Yield-0.44%

    Peer Position

    Against 10 similar companies, MMSI has the 6th highest P/E.

    P/E Ratio20.7x vs 21.1x median
    P/S Ratio3.1x vs 2.9x median
    ROIC6.96% vs 6.74% median
    Revenue Growth (Trailing 4 Quarters, YoY)+9.06% vs +6.20% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.14% and EPS growth at 10.42% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.14%
    EPS Growth Forecast (2Y CAGR)+10.42%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MMSI

    What is MMSI's market cap?

    Merit Medical Systems has a market cap of $5.17B. Its enterprise value, which adds debt and subtracts cash, is $5.41B.

    What is MMSI's P/E ratio?

    Merit Medical Systems has a trailing P/E ratio of 20.7x and a forward P/E of 19.0x.

    How many shares of MMSI are outstanding?

    Merit Medical Systems has 59.81M shares outstanding. The count is up 0.95% from a year earlier.

    Does MMSI pay a dividend?

    No. Merit Medical Systems does not pay a dividend.

    How much debt does MMSI have?

    Merit Medical Systems has $737.40M of total debt and $503.55M of cash and equivalents, a net debt position of $233.85M.